Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

High Pretreatment Plasma D-Dimer Levels Are Associated with Poor Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphomas Treated with Immunochemotherapy

Atsushi Tanaka, MD, Yoshimitsu Shimomura, MD, Tomohiro Yabushita, MD, Takayuki Ishikawa

Blood (2018) 132 (Supplement 1): 4219.

https://doi.org/10.1182/blood-2018-99-115550

Published: 2018

Journal Articles

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

Yoshimitsu Shimomura, MD, Hayato Maruoka, PhD, Tomohiro Yabushita, MD, Hisako Hashimoto, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 2000.

https://doi.org/10.1182/blood.V130.Suppl_1.2000.2000

Published: 2017

Journal Articles

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

Tomohiro Yabushita, MD, Hayato Maruoka, PhD, Yoshimitsu Shimomura, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD PhD, Hisako Hashimoto, MD PhD, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 420.

https://doi.org/10.1182/blood.V130.Suppl_1.420.420

Published: 2017

Journal Articles

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Daisuke Kato, MD, Satoshi Yoshioka, MD, PhD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2966.

https://doi.org/10.1182/blood.V128.22.2966.2966

Published: 2016

Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1480.

https://doi.org/10.1182/blood.V126.23.1480.1480

Published: 2015

NARROW

High Pretreatment Plasma D-Dimer Levels Are Associated with Poor Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphomas Treated with Immunochemotherapy

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

High Pretreatment Plasma D-Dimer Levels Are Associated with Poor Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphomas Treated with Immunochemotherapy

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only